Hyperglycemia Induces Neutrophil Extracellular Traps Formation Through an NADPH Oxidase-Dependent Pathway in Diabetic Retinopathy

Front Immunol. 2019 Jan 8:9:3076. doi: 10.3389/fimmu.2018.03076. eCollection 2018.

Abstract

Neutrophil extracellular traps (NETs), the product of NETosis, is found to localize pathogens and crystals in immune response. Recent studies have found that excessive NETs lead to disease conditions such as diabetes and its complications like diabetic retinopathy (DR). However, the correlation between NETs and high glucose or DR remains unclear. Here, we found NETs level was significantly increased in the serum of diabetic patients, especially in proliferation diabetic retinopathy (PDR) patients. High glucose dramatically increased NETs production in diabetic individuals with time prolonging. The activation of NADPH oxidase was involved in the NETs process which is triggered by high glucose. Moreover, we verified the infiltration of neutrophils in the eyes and adhesion to vascular endothelial cells in diabetic rat models. NETs formation was observed in the vitreous bodies and retinas of diabetic individuals, which indicates NETs may play a role in the pathogenesis of diabetic retinopathy. Furthermore, anti-VEGF therapy downregulates NETs production indicating that NADPH oxidase-derived ROS may be another signaling pathway involved in anti-VEGF therapy.

Keywords: NADPH oxidase; diabetic retinopathy (DR); hyperglycemia; neutrophil extracellular traps (NETs); type 2 diabetes mellitus.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Analysis of Variance
  • Animals
  • Cell Adhesion
  • Chi-Square Distribution
  • Diabetes Mellitus, Type 2 / complications*
  • Diabetes Mellitus, Type 2 / drug therapy
  • Diabetic Retinopathy / blood
  • Diabetic Retinopathy / drug therapy
  • Diabetic Retinopathy / etiology*
  • Diabetic Retinopathy / metabolism*
  • Disease Models, Animal
  • Endothelial Cells / physiology
  • Extracellular Traps / drug effects
  • Extracellular Traps / metabolism*
  • Humans
  • Hyperglycemia / metabolism*
  • Intravitreal Injections
  • NADPH Oxidases / metabolism*
  • Neutrophil Infiltration / physiology
  • Rats
  • Reactive Oxygen Species / metabolism
  • Recombinant Fusion Proteins / administration & dosage
  • Recombinant Fusion Proteins / pharmacology
  • Recombinant Fusion Proteins / therapeutic use
  • Signal Transduction / drug effects
  • Statistics, Nonparametric
  • Vascular Endothelial Growth Factor A / antagonists & inhibitors
  • Vascular Endothelial Growth Factor A / metabolism
  • Vitreous Body / metabolism

Substances

  • Reactive Oxygen Species
  • Recombinant Fusion Proteins
  • VEGFA protein, human
  • Vascular Endothelial Growth Factor A
  • vascular endothelial growth factor A, rat
  • KH902 fusion protein
  • NADPH Oxidases